Paper: Development challenges for hybrid applications of DPIs. Could IVIVC tools predict in vivo conditions? A case study with Elpenhaler device.
Stavroula Rozou is a skilled pharmacist with 29-years industrial experience and a specialism in respiratory drug products, with a track-record of leading product development teams (including formulation, analytical, device and CMC) to deliver cost-effective generic and hybrid products to major markets around the world. Author of numerous peer-reviewed papers, presenter at industry symposiums and organiser of two COST SimInhale conferences, an EU-funded Horizon 2020 initiative. A capable problem-solver, liaising with global regulators to ensure product approvals occur in an efficient and timely manner, delivering value and short-time to market. Current role in ELPEN Pharmaceuticals involves proposal and evaluation of the respiratory product pipeline along with strategies to de-risk development.